Doug Altman was an internationally renowned statistician who served as The BMJ’s chief statistical adviser.
Read about life and work that made this statistician a "citation millionaire"
#BMJChristmas
www.bmj.com/content/391/...
The first 12 months of our project evaluating same-day emergency care (SDEC) is nearly over.
You can read about how the project is progressing on our website:
sites.google.com/sheffield.ac...
@fohsheffield.bsky.social @scharr-msg.bsky.social @arc-yharc.bsky.social
#SDEC #NHS #NIHR
Our PhD student is looking for children aged 5-16 with asthma in the UK to complete a survey to better understand inhaler use during the summer holidays among children and adolescents with asthma:
shef.qualtrics.com/jfe/form/SV_...
Please forward on.
@stevenjulious.bsky.social
Had a paper published with Laura Flight and @alan-brennan.bsky.social entitled
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges
doi.org/10.1186/s128...
Next Thursday, June 5th at 1pm (BST) we host our 4th webinar in our adverse event special series. Rayan Taher & Jenny Yiend will present their work on developing a process for assessing the safety of a digital mental health intervention & gaining regulatory approval. Register here: lnkd.in/eaW3MQrB
The protocol for MissionEB - a randomised, double-blinded, placebo-controlled, two-centre, crossover trial - a study to assess mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa has just published
doi.org/10.1136/bmjo...
A great talk at #SCT2025 by James Salsbury entitled
Assurance methods for designing a survival trial with delayed treatment effects
Attending an excellent talk by Nikki Totton at #SCT2025 entitled
Using benefit risk methods to adjust the non-inferiority margin based on treatment benefits
In clinical trials it is not only potential benefits that should be measured - it is crucially important that any potential #harms are also investigated 1/7
#MethodologyMonday #118
Had a paper published with Kelly Grant on the analysis of recurrent events in clinical trials
We recommend that the conditional frailty model be used for these data trials, including cluster randomised trials, to help explain changes in event risk over time, and assist clinical interpretation
Comparison of statistical methods for the analysis of patient-reported outcomes (PROs), particularly the Short-Form 36 (SF-36), in randomised controlled trials (RCTs) using standardised effect size (SES): an empirical analysis
hqlo.biomedcentral.com/articles/10....
Second paper from the prosec3 study: Further development of a patient-reported outcome measure to assess the impact of oral secretion problems in people living with MND www.tandfonline.com/doi/full/10....
New paper!! Estimating the minimum important difference in the ALSFRS-R-instrument in people living with MND www.tandfonline.com/doi/full/10....
Today's date
5-2-25
Is a palindrome
